Relationship between Barkhof criteria and the clinical features of multiple sclerosis in northern Japan

Multiple Sclerosis

Volumn 15, Issue 12, 2009, Pages 1450-1458

  Nakamura, M ^a   Houzen, H ^a   Niino, M ^b   Tanaka, K ^c   Sasaki, H ^b  

^a Obihiro Kosei General Hospital   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Epidemiology; Incidence; Magnetic resonance imaging; Multiple sclerosis; Prevalence; Spinal cord

Indexed keywords

ANTIBODY; AQUAPORIN 4 ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BARKHOF CRITERIA; BRAIN DAMAGE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CONVENTIONAL MULTIPLE SCLEROSIS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; FEMALE; HUMAN; INCIDENCE; JAPAN; MALE; MULTIPLE SCLEROSIS; OPTICOSPINAL MULTIPLE SCLEROSIS; SPINAL CORD LESION; TREND STUDY;

ADULT; AGE FACTORS; AQUAPORIN 4; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; BRAIN; DISABILITY EVALUATION; FEMALE; HUMANS; INCIDENCE; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; OPTIC NERVE; PREDICTIVE VALUE OF TESTS; PREVALENCE; SPINAL CORD;

EID: 72749089892     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509350305     Document Type: Article

References (43)

1. McDonald WI, Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001 ; 50: 121-127.
2. Polman CH, Reingold SC, Edan G., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald criteria. Ann Neurol 2005 ; 58: 840-846.
3. Barkhof F., Filippi M., Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997 ; 120: 2059-2069.
4. TintorÉ M., Rovita A., Martinez MJ, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 2000 ; 21: 702-706.
5. Korteweg T., TintorÉ M., Uitdehaag B., et al. MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study. Lancet Neurol 2005 ; 5: 221-227. (Pubitemid 43238345)
6. Dalton CM, Brex PA, Miszkiel KA, et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002 ; 52: 47-53.
7. TintorÉ M., Rovita A., Rio J., et al. New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology 2003 ; 60: 27-30.
8. Nielsen JM, Korteweg T., Barkhof F., Uitdehaag BM, Polman CH Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria. Ann Neurol 2005 ; 58: 781-783.
9. Bot JC, Barkhof F., Polman CH, et al. Spinal cord abnormalities in recently diagnosed MS patients. Neurology 2004 ; 62: 226-233.
10. Matsuoka T., Matsushima T., Osoegawa M., et al. Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings. J Neurol Sci 2008 ; 266: 115-125.
11. Fukazawa T., Tashiro K., Hamada T., et al. Multiple sclerosis in Hokkaido, the northernmost island of Japan: prospective analyses of clinical features. Intern Med 1992 ; 31: 349-352.
12. Kira J., Kanai T., Nishimura Y., et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996 ; 40: 569-574.
13. Misu T., Fujihara K., Nakashima I., et al. Pure optic-spinal form of multiple sclerosis in Japan. Brain 2002 ; 125: 2460-2468.
14. Ma JJ, Nishimura M., Mine H., et al. HLA-DRB1 and tumor necrosis factor gene polymorphisms in Japanese patients with multiple sclerosis. J Neuroimmunol 1998 ; 92: 109-112.
15. Ono T., Zambenedetti MR, Yamasaki K., et al. Molecular analysis of HLA class I (HLA-A and -B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (western type and Asian type). Tissue Antigens 1998 ; 52: 539-542.
16. Compston DA, Keller WH, Robertson N., Sawcer S., Wood NW Genes and susceptibility to multiple sclerosis. Acta Neurol Scand Suppl 1995 ; 161: 43-51.
17. Yamasaki K., Horiuchi I., Minohara M., et al. HLA-DPB1*0501- associated opticospinal multiple sclerosis. Clinical, neuroimaging and immunogenetic studies. Brain 1999 ; 122: 1689-1696.
18. Ito H., Yamasaki K., Kawano Y., et al. HLA-DPassociated susceptibility to the optico-spinal form of multiple sclerosis in the Japanese. Tissue Antigens 1998 ; 52: 179-182.
19. Fukazawa T., Kikuchi S., Miyagishi R., et al. HLA-DPB1*0501 is not uniquely associated with opticospinal multiple sclerosis in Japanese patients. Important role of DPB1*0301. Mult Scler 2006 ; 12: 19-23.
20. Houzen H., Niino M., Kikuchi S., et al. The prevalence and clinical characteristics of MS in northern Japan. J Neurol Sci 2003 ; 211: 49-53.
21. Houzen H., Niino M., Hata D., et al. Increasing prevalence and incidence of multiple sclerosis in northern Japan. Mult Scler 2008 ; 14: 887-892.
22. Kira J., Yamasaki K., Horiuchi I., Ohyagi Y., Taniwaki T., Kawano Y. Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan. J Neurol Sci 1999 ; 166: 53-57.
23. Mayr WT, Pittock SJ, McClelland RL, Jorgensen NW, Noseworthy JH, Rodriguez M. Incidence and prevalence of multiple sclerosis in Olmsted county, Minnesota, 1985-2000. Neurology 2003 ; 61: 1373-1377.
24. Grytten N., Glad SB, Aarseth JH, Nyland H., Midgard R., Myhr KM A 50 year follow-up of the incidence of multiple sclerosis in Hordaland county, Norway. Neurology 2006 ; 66: 182-186.
25. Hader WJ, Yee IM Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan. Neurology 2007 ; 69: 1224-1229.
26. Grimaldi LM, Palmeri B., Salemi G., et al. High prevalence and fast rising incidence of multiple sclerosis in Caltanissetta, Sicily, southern Italy. Neuroepidemiology 2007 ; 28: 28-32.
27. Shibasaki H., McDonald WI, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci 1981 ; 49: 253-271.
28. Nakashima I., Fujihara K., Okinaka N., Takase S., Itoyama Y. Clinical and MRI study of brain stem and cerebellar involvement in Japanese patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 1999 ; 67: 153-157.
29. Su JJ, Osoegawa M., Matsuoka T., et al. Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings. J Neurol Sci 2006 ; 243: 21-30.
30. Matsuoka T., Matsushita T., Kawano Y., et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007 ; 130: 1206-1223.
31. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004 ; 364: 2106-2112.
32. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG Revised diagnostic criteria for neuromyelitis optica. Neurology 2006 ; 66: 1485-1489.
33. Nakashima I., Fujihara K., Miyazawa I., et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006 ; 77: 1073-1075.
34. Pittock SJ, Lennon VA, Krecke K., Wingerchuk DM, Lucchinetti CF, Weinshenker BG Brain abnormalities in neuromyelitis optica. Arch Neurol 2006 ; 63: 390-396.
35. Poser CM, Paty DW, Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 ; 13: 227-231.
36. Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983 ; 33: 1444-1452.
37. Tanaka K., Tani T., Tanaka M., et al. Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler 2007 ; 13: 850-855. (Pubitemid 351540855)
38. Osoegawa S., Kira J., Fukazawa T., et al. Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler 2009 ; 15: 159-173.
39. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2003 ; 2: 117-127.
40. Saida T., Tashiro K., Itoyama Y., et al. Interferon beta-1b is effective in Japanese RRMS patients. A randomized, multicenter study. Neurology 2005 ; 64: 621-630.
41. Tartaglino LM, Friedman DP, Flanders AE, Lubin FD, Knobler RL, Liem M. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 1995 ; 195: 725-732.
42. Lycklama G., Thompson A., Fillppi M., et al. Spinal-cord MRI in multiple sclerosis. Lancet Neurol 2003 ; 2: 555-562.
43. Nijeholt GJ, van Walderveen MA, Castelijns JA, et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 1998 ; 121: 687-697.